Study: Japanese Pharmaceutical Company Finds Ivermectin Has An ‘Antiviral Effect’ Against Omicron And Other Coronavirus Variants

Kowa said the renowned drug has antiviral properties against all existing strains of SARS-CoV2 and is expected to be widely-used as a coronavirus therapeutic.

Ivermectin - Shutterstock


Japanese conglomerate and pharmaceuticals company Kowa found that ivermectin has an “antiviral effect” against the Omicron strain of coronavirus, the company announced Monday.

In a press release, Kowa said that the renowned anti-parasitic drug shows antiviral properties in a lab setting against the new variant and all other existing strains of the virus, including Alpha, Beta, Gamma, and Delta.


Researchers previously found that ivermectin inhibits replication and intracellular entry of coronavirus in laboratory studies, Kowa noted. The company added that it expects the drug to be applied as a therapeutic for all new coronavirus diseases.

Read More

Leave a Reply


Hypocrite: Neil Young Who Criticized Podcaster Joe Rogan For Alleged COVID ‘Misinformation’ Previously Attacked The Gay Community With False Info On AIDS Transmission

The Pedophilia And Sex Network: CNN President Jeff Zucker Latest Departure After Failure To Disclose Relationship With Key Staffer